Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis(University of Minnesota), Michael A. Carducci(Sidney Kimmel Comprehensive Cancer Center), Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center), Amanda L. Blackford(Johns Hopkins University), Michelle A. Rudek(Dana-Farber Cancer Institute), Ming Zhao(Sidney Kimmel Comprehensive Cancer Center), Janet Mendonca(Sidney Kimmel Comprehensive Cancer Center), Daniel C. Danila, Serina King(Sidney Kimmel Comprehensive Cancer Center), Anja S. Frost(Johns Hopkins University), Sushant K. Kachhap(Johns Hopkins University), Elisabeth I. Heath(The Barbara Ann Karmanos Cancer Institute), David C. Smith(University of Michigan), A. Seun Ajiboye(Sidney Kimmel Comprehensive Cancer Center)
Cited by 178
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k